[1]
Sorrentino, L.M., Iacuzzo, C., Sciri, R., Zacchia, M., Iannuzzi, M., Marotta, P., Vitale, P., Taglioni, C., Secondulfo, F., Palazzetti, D. and Baccaro, R. 2025. Ravulizumab in treatment-naïve patients with atypical hemolytic uremic syndrome: a real-world case series. Drug Target Insights. 19, 1 (Dec. 2025), 99–107. DOI:https://doi.org/10.33393/dti.2025.3616.